OR WAIT null SECS
Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.
September 08, 2024
Insights into molecular behaviors and predictive capabilities are bringing numerous benefits.
August 08, 2024
A holistic approach to automation can provide benefits at all stages of development and manufacturing.
August 07, 2024
Platform processes and effective risk assessments help overcome time and cost challenges.
July 09, 2024
Weighing development costs/resources and performance benefits is essential.
June 09, 2024
Artificial intelligence and machine learning can help overcome poor solubility and bioavailability.
May 06, 2024
The use of appropriate taste-masking and appearance technologies can facilitate patient compliance.